T-cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model: Tumor neutralization in winn type assays

Keyphrases

• Tumor 100%
• Colon Adenocarcinoma 100%
• Bispecific Monoclonal Antibody 100%
• Rat Colon 100%
• T-cell Retargeting 100%
• Effector Cells 66%
• Recombinant IL-2 66%
• Tumor Growth 33%
• T Cell Receptor 33%
• Syngeneic 33%
• Bispecific 33%
• Antitumor Activity 33%
• Tumor-like Lesions 33%
• CD8+ T Lymphocytes 33%
• Natural Killer 33%
• CC531 33%
• Colon Cancer Cells 33%
• Subcapsular 33%
• Unsatisfactory Outcome 33%
• Tumor-specific Antibodies 33%
• Co-cultivation 33%

Immunology and Microbiology

• T Cell 100%
• Colon 100%
• Neutralization 100%
• Bispecific Monoclonal Antibody 100%
• Rat 100%
• Effector Cell 66%
• Interleukin 2 66%
• Syngenic 33%
• T Cell Receptor 33%
• Carcinoma Cell 33%
• Antineoplastic Activity 33%
• Coculture 33%
• CD8+ T Lymphocyte 33%
• Cancer Antibody 33%
• In Vitro 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Neoplasm 100%
• Tumor Model 100%
• Monoclonal Antibody 100%
• Colon Carcinoma 100%
• Rat 100%
• Interleukin 2 50%
• Tumor Growth 25%
• CD8 Antigen 25%
• T Lymphocyte Receptor 25%
• Cancer Antibody 25%